With Fermion, start the journey of your innovative API.
01 1Fermion Oy
02 1Emcure Pharmaceuticals Limited
03 1Hetero Labs Limited
04 1Hubei Haosun Pharmaceutical Co., Ltd.
05 1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
06 1Laurus Labs Limited
07 1Olon SpA
08 1Qilu Pharmaceutical Co., Ltd.
09 1SHILPA PHARMA LIFESCIENCES LIMITED
10 1ScinoPharm Taiwan Ltd.
11 1Shandong Anxin Pharmaceutical Co., Ltd.
12 1Sichuan Xieli Pharmaceutical Co., Ltd.
01 1IRINOTECAN HYDROCHLORIDE
02 1Irinotecan
03 1Irinotecan HCl
04 7Irinotecan Hydrochloride
05 2Irinotecan Hydrochloride Trihydrate
01 4China
02 1Finland
03 4India
04 1Italy
05 1Taiwan
06 1United Kingdom
NDC Package Code : 12780-4860
Start Marketing Date : 2007-06-29
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14593-828
Start Marketing Date : 2023-12-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (5kg/5kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14778-1111
Start Marketing Date : 2011-10-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 57884-0009
Start Marketing Date : 2007-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42385-711
Start Marketing Date : 2008-11-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17337-0307
Start Marketing Date : 2012-03-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 67184-0014
Start Marketing Date : 2024-10-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 35369-0020
Start Marketing Date : 2023-07-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (3kg/3kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65129-1025
Start Marketing Date : 2003-07-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61200-112
Start Marketing Date : 2015-05-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER, FOR SUSPENSION (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
A Irinotecan Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Irinotecan Hydrochloride, including repackagers and relabelers. The FDA regulates Irinotecan Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Irinotecan Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Irinotecan Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Irinotecan Hydrochloride supplier is an individual or a company that provides Irinotecan Hydrochloride active pharmaceutical ingredient (API) or Irinotecan Hydrochloride finished formulations upon request. The Irinotecan Hydrochloride suppliers may include Irinotecan Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Irinotecan Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Irinotecan Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Irinotecan Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Irinotecan Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Irinotecan Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Irinotecan Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Irinotecan Hydrochloride suppliers with NDC on PharmaCompass.
We have 12 companies offering Irinotecan Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?